Keros Therapeutics Inc. (KROS)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

1,679,417 $91,327 1.48%
2. 1,380,306 $75,061 +7% 4.81%
3.
Alkeon Capital Management

Panayotis Takis Sparaggis

906,433 $49,291 -3% 0.09%
4.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

816,830 $44,419 +3% 1.96%
5. 340,214 $18,501 3.99%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$50.00 6,000 Large Shareholder, Director 155,262 2020-11-17 Filing
$50.00 14,400 Large Shareholder, Director 1,228,326 2020-11-17 Filing
$50.00 12,966 Large Shareholder, Director 1,122,768 2020-11-17 Filing
$50.00 26,634 Large Shareholder, Director 2,288,151 2020-11-17 Filing
$50.00 6,000 Large Shareholder, Director 155,262 2020-11-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$45.45 16 Officer 85,700 2022-05-11 Filing
$44.23 223 Officer 85,716 2022-05-11 Filing
$43.32 719 Officer 85,939 2022-05-11 Filing
$42.49 944 Officer 86,658 2022-05-11 Filing
$41.26 3,398 Officer 87,602 2022-05-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 25,000 $1,360,000 0.02%
2. 8,010 $435,584 0%
3. 3,007,936 $163,571 0.01%
4. 1,298,046 $70,588 0%
5. 736,593 $40,056 0%
News See All